Strategic Expansion Transpharmation has recently expanded its neuroscience focus through a strategic alliance with InterVivo Solutions to form the largest boutique neuroscience specialised small and large animal CRO, presenting opportunities to cross-sell integrated preclinical services to a broader client base seeking end-to-end translational solutions.

Data Analytics Offering Launched a dedicated data analysis service using proprietary tremor-monitor data algorithms, creating a new recurring value proposition for clients with existing preclinical datasets and offering upsell potential for enhanced data-driven decision making alongside core translational biology services.

Global Collaborative Model Emphasize flexible collaboration in contract work or full-time capacity worldwide, enabling sales strategies that target pharma and biotech companies seeking adaptable research partnerships, rapid turnaround, and scalable CRO support across regions.

Accredited Quality Agenda Life Sciences holds AAALAC accreditation, signaling high standards in scientific validity and robust outcomes; leverage this for competitive differentiation when bidding for international preclinical programs and for clients prioritizing accredited facilities.

Neuroscience Specialization Position Transpharmation as a premier partner for neuroscience translational workflows, with capabilities across cross-species and cross-therapeutic areas, including pain and sleep models, to attract clients developing CNS therapies seeking validated behavioural and molecular assays.